Literature DB >> 16201706

Anthrax: pathological aspects in autopsy cases in Shiraz, Islamic Republic of Iran, 1960-2001.

S Z Tabei1, A Amin, A Mowla, S A Nabavizadeh, A Razmkon.   

Abstract

Anthrax, like tuberculosis, shows a new epidemic spread in industrialized countries, revealing some ambiguous aspects to the disease and providing new challenges to medicine. Shiraz University of Medical Sciences has records of 7130 autopsies performed in the past 40 years, 33 of which are anthrax cases. We reviewed all the pathology slides of these cases and classified the organs involved in a search for unrecognized microscopic findings. The most common cause of death was sepsis, caused by organ involvement and direct cytotoxicity of Bacillus anthracis, in addition to its exotoxin production. Novel findings included hyaline membrane formation in respiratory system cases that is similar to acute (adult) respiratory distress syndrome and evidence of primary gastrointestinal involvement, showing the ability of the organism to pass the gastric barrier.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16201706

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  3 in total

1.  Gastrointestinal anthrax: clinical experience in 5 cases.

Authors:  Ghodratollah Maddah; Abbas Abdollahi; Mehrdad Katebi
Journal:  Caspian J Intern Med       Date:  2013

2.  The phenotypic and genotypic characterization of Bacillus anthracis isolates from Iran.

Authors:  Gholamreza Moazeni Jula; Morteza Sattari; Reza Banihashemi; Hossein Razzaz; Alireza Sanchouli; Keyvan Tadayon
Journal:  Trop Anim Health Prod       Date:  2010-11-30       Impact factor: 1.559

Review 3.  Does Bacillus anthracis Lethal Toxin Directly Depress Myocardial Function? A Review of Clinical Cases and Preclinical Studies.

Authors:  Dante A Suffredini; Hanish Sampath-Kumar; Yan Li; Lernik Ohanjanian; Kenneth E Remy; Xizhong Cui; Peter Q Eichacker
Journal:  Toxins (Basel)       Date:  2015-12-12       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.